GL1X · GenesisL1 explorer

Research workbench

Avoiding drug resistance against HCV NS3/4A protease inhibitors

Analyse Avoiding drug resistance against HCV NS3/4A protease inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3M5M
Type
protein
Length
401 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NS3/4A; Fdemeec peptide
EC
3.4.21.98
UniProt
A8DG50, Q9WPH5
Ligands
ACE, ZN, SO4
Pockets
3 · best druggability 0.38

Structure

x-ray diffraction · 2 distinct chains · 12% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BNS3/4A (EC 3.4.21.98)protein19713% helix, 43% strandA8DG50
CFdemeec peptideprotein70% helix, 57% strandQ9WPH5

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains B, C
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1630.380.7917empty
21330.380.7422empty
3910.350.7520empty

Interfaces

2 interfaces between chains.

  • B–C · 551 Ų buried · 13 hydrogen bonds · protein-protein
  • A–B · 258 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 3M5M · Avoiding drug resistance against HCV NS3/4A protease inhibitors · the same entry in another collection · chain C against C, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.